Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.
bill electronically reproduced 05/12/2026
Email me when HB 5941 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 5941. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill obligates prescription drug manufacturers to file detailed reports with the state before raising the wholesale acquisition cost of drugs that cost more than $40 per treatment course by 5% in a single year or 15% over three years. It also requires near‑real‑time notice for new specialty drugs and mandates an annual public summary report, imposing civil fines for missed filings.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 5941
3 free questions a day, no accountHistory
- bill electronically reproduced 05/12/2026
- referred to Committee on Health Policy
- read a first time
- introduced by Representative Rep. Karl Bohnak
Sponsors
- Karl Bohnak · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 5941 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 5941 freeOr ask your AI assistant about HB 5941 directly:
Add to Claude, ChatGPT or Cursor